Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.31
(-1.61%)
AUD 0.31
(-1.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -58.65 Million AUD | -12.99% |
| 2023 | -51.91 Million AUD | -32.26% |
| 2022 | -39.24 Million AUD | -14.44% |
| 2021 | -34.29 Million AUD | -178.86% |
| 2020 | -12.29 Million AUD | 21.3% |
| 2019 | -15.62 Million AUD | -152.45% |
| 2018 | -6.19 Million AUD | -44.79% |
| 2017 | -4.27 Million AUD | -46.2% |
| 2016 | -2.92 Million AUD | -86.83% |
| 2015 | -1.56 Million AUD | -576.34% |
| 2014 | -231.43 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -48.95 Million AUD | 0.0% |
| 2024 Q4 | -9.69 Million AUD | 0.0% |
| 2024 FY | -58.65 Million AUD | -12.99% |
| 2023 Q4 | -20.04 Million AUD | 0.0% |
| 2023 Q2 | -31.86 Million AUD | 0.0% |
| 2023 FY | -51.91 Million AUD | -32.26% |
| 2022 Q4 | -12.26 Million AUD | 0.0% |
| 2022 FY | -39.24 Million AUD | -14.44% |
| 2022 Q2 | -26.98 Million AUD | 0.0% |
| 2021 FY | -34.29 Million AUD | -178.86% |
| 2021 Q4 | -13.56 Million AUD | 0.0% |
| 2021 Q2 | -20.73 Million AUD | 0.0% |
| 2020 Q4 | -7.19 Million AUD | 0.0% |
| 2020 Q2 | -5.1 Million AUD | 0.0% |
| 2020 FY | -12.29 Million AUD | 21.3% |
| 2019 Q2 | -4.4 Million AUD | 0.0% |
| 2019 FY | -15.62 Million AUD | -152.45% |
| 2019 Q4 | -11.22 Million AUD | 0.0% |
| 2018 Q2 | -3.57 Million AUD | 0.0% |
| 2018 Q4 | -2.61 Million AUD | 0.0% |
| 2018 FY | -6.19 Million AUD | -44.79% |
| 2017 Q2 | -2.81 Million AUD | 0.0% |
| 2017 FY | -4.27 Million AUD | -46.2% |
| 2017 Q4 | -1.45 Million AUD | 0.0% |
| 2016 Q4 | -1.5 Million AUD | 0.0% |
| 2016 FY | -2.92 Million AUD | -86.83% |
| 2016 Q2 | -1.42 Million AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 Q4 | -959.98 Thousand AUD | 0.0% |
| 2015 FY | -1.56 Million AUD | -576.34% |
| 2015 Q2 | -605.32 Thousand AUD | 0.0% |
| 2014 FY | -231.43 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -989.951% |
| Acrux Limited | -5.8 Million AUD | -911.262% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -1202.405% |
| Biome Australia Limited | -1.67 Million AUD | -3411.742% |
| BTC Health Limited | 1.05 Million AUD | 5658.032% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -368.108% |
| CSL Limited | 2.64 Billion AUD | 102.22% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | -38.58% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 264.588% |
| Noxopharm Limited | -3.57 Million AUD | -1539.219% |
| PharmAust Limited | -9.03 Million AUD | -549.368% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -819.874% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -611.979% |
| PYC Therapeutics Limited | -37.72 Million AUD | -55.474% |
| Race Oncology Limited | -13.81 Million AUD | -324.428% |
| Starpharma Holdings Limited | -8.16 Million AUD | -618.349% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 942.175% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -322.887% |
| Memphasys Limited | -4.44 Million AUD | -1220.417% |
| Nyrada Inc. | -1.38 Million AUD | -4131.139% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -3941.586% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 1225.565% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -2334.572% |
| Zelira Therapeutics Limited | -36.56 Million AUD | -60.391% |
| Patrys Limited | -3.53 Million AUD | -1557.268% |
| Dimerix Limited | -17.07 Million AUD | -243.502% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 137.339% |
| Orthocell Limited | -7.18 Million AUD | -716.788% |
| Imugene Limited | -149.68 Million AUD | 60.814% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -501.898% |
| Immutep Limited | -39.89 Million AUD | -47.014% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -570.626% |
| Alterity Therapeutics Limited | -19.12 Million AUD | -206.708% |
| Nanollose Limited | -1.15 Million AUD | -4971.379% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -3472.473% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 18191.11% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -1947.719% |
| Biotron Limited | -3.43 Million AUD | -1606.759% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | -22.324% |
| Tissue Repair Ltd | -4.13 Million AUD | -1317.393% |
| AnteoTech Limited | -8.88 Million AUD | -560.47% |
| Hexima Limited | -933.87 Thousand AUD | -6180.639% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | -232.092% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -1606.741% |
| Actinogen Medical Limited | -13.04 Million AUD | -349.647% |
| Immuron Limited | -6.93 Million AUD | -745.518% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -970.414% |